About Synthace
Synthace is a company based in London (United Kingdom) founded in 2011 by Markus Christian Gershater. Synthace has raised $80.27 million across 8 funding rounds from investors including Horizons Ventures, Sofinnova Partners and SOSV. The company has 68 employees. Synthace offers products and services including Synthace Software, DOE Training Course, and Dilution Calculator. Synthace operates in a competitive market with competitors including Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others.
- Headquarter London, United Kingdom
- Employees 68
- Founders Markus Christian Gershater
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synthace.com
- Social LinkedIn X Facebook
- Legal Name Synthace Limited
- Date of Incorporation 31 May, 2011
- Jurisdiction LONDON, ENGLAND
- Annual Revenue$2.41 M (USD)47as on Jan 31, 2023
- Net Profit-$11.58 M (USD)-7as on Jan 31, 2023
- EBITDA-$13.47 M (USD)-5as on Jan 31, 2023
- Total Equity Funding$80.27M (USD)
in 8 rounds
- Latest Funding Round$35M (USD), Series C
Nov 2021
- InvestorsHorizons Ventures
& 8 more
- Employee Count68
Products & Services of Synthace
Synthace offers a comprehensive portfolio of products and services, including Synthace Software, DOE Training Course, and Dilution Calculator.
Software for automating and optimizing biological experiments.
Training on Design of Experiments for scientific research.
Online tool for accurate dilution calculations in labs.
Funding Insights of Synthace
Synthace has successfully raised a total of $80.27M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $35 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $80.27M
- Total Rounds 8
- Last Round Series C — $35M
- First Round $965,000
(Apr 2012)
- Investors Count 9
All 8 funding rounds of Synthace with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $35M | Series C | – | Horizons Ventures, Sofinnova Partners | – |
| Dec 2018 | $25.6M | Series B | $71.3M | Horizons Ventures | |
| May 2018 | $3.1M | Series A | $27.7M | – | – |
| Sep 2017 | $10.1M | Series A | – | Amadeus Capital, White Cloud Capital | |
| Jan 2015 | $3.4M | Series A | – | SOSV, Bioeconomy Capital | – |
| Aug 2013 | $2.1M | Seed | $••••• | Sofinnova Partners | – |
| Mar 2013 | $754,870 | Grant | – | – | – |
| Apr 2012 | $965,000 | Seed | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Dec 2018 | $71.3M | •••••••• |
| May 2018 | $27.7M | •••••••• |
| Aug 2013 | $••••• | •••••••• |
Full valuation and stage history of Synthace
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $71.3M (Dec 2018). 9 investors in total: 9 institutional.
Investors in Synthace
Synthace has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizons Ventures, Sofinnova Partners and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Horizons Ventures is focused on investing in deep science and technology. | – | horizonsventures.com | Hong Kong, China | |
Sofinnova Partners is focused on life sciences and healthcare investments. | – | sofinnovapartners.com | Paris, France | |
Venture capital and accelerator services are provided across multiple sectors. | – | sosv.com | Cork, Ireland | |
Early-stage startups are funded by Luminous Ventures venture capital firm. | – | luminous.vc | London, United Kingdom | |
Early-stage deep technology investments are made by Amadeus Capital. | – | amadeuscapital.com | London, United Kingdom | |
- | – | bioeconomycapital.com | - | |
Strategic venture capital investments are made in growing companies. | 2014 | whcloud.com | London, United Kingdom | |
Venture capital investments are provided to innovative founders. | – | 112capital.com | San Francisco, United States | |
Early-stage innovations are funded by UKI2S across key sectors. | – | ukinnovationscienceseedfund.co.uk | Manchester, United Kingdom |
Investor details for Synthace
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synthace
19 people are tracked at Synthace (5 in leadership, 6 in board & advisors, 8 in team); the tracked headcount is 68.
| Name | Role | Group |
|---|---|---|
Markus Christian Gershater | Co-Founder & CEO | Leadership |
Abdul Rahim Bah | Director of Engineering | Leadership |
Brian Danforth | VP, Sales | Leadership |
James Smith | Sales Director | Leadership |
James Arpino | Director Of Product Management | Leadership |
Bill Liao | Observer | Board & advisors |
Tom Burt | Non-Executive Director | Board & advisors |
Sami Mikati | Observer | Board & advisors |
Markus Gershater | Co-Founder & Chief Scientific Officer | Board & advisors |
Patrick Zhang | Non-Executive Director | Board & advisors |
Joško Bobanović | Observer | Board & advisors |
Prince Ikeru | Associate Business Development Manager | Team |
Nalini Yadav | Account Executive | Team |
Matthew Gregg | Software Developer | Team |
Bruno Savioli de Almeida | Site Reliability Engineer | Team |
Stephanie Volk | Global Manager, Customer Success | Team |
Tara B. | Business Operations Associate | Team |
Dean Hervey | Advisor | Team |
Vladislav Bogomolov | Senior Software Engineer | Team |
Complete people profiles for Synthace
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Synthace
4 dated milestones of Synthace across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Synthace is founded.
- Funding First funding round of $965K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series C, of $35.0M.
Competitors of Synthace
Synthace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Tecan, Emerald Therapeutics, Quartzy and CrelioHealth, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| waters.com | 1958 | Milford, United States | – | 9,341 | Provider of laboratory management system for researchers and clinicians | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| emeraldcloudlab.com | 2010 | San Francisco, United States | $39.5M | 77 | Cloud-based remote lab automation software is offered for life sciences. | |
| quartzy.com | 2009 | Palo Alto, United States | $33.87M | 97 | Lab management platform for life sciences is offered by Quartzy. | |
| creliohealth.com | 2013 | Pune, India | $1.5M | 156 | SaaS-based laboratory information system is provided for clinicians. | |
| automata.tech | 2015 | London, United Kingdom | $106.51M | 151 | Lab automation robots are provided for life sciences applications. | |
| indigobio.com | 2004 | Indianapolis, United States | $12.35M | 27 | Laboratory automation software is developed by Indigo BioAutomation. | |
| monomerbio.com | 2021 | Pacifica, United States | $5.6M | – | Provider of lab automation solutions for biology research | |
| inpeco.com | 1990 | Novazzano, Switzerland | – | – | Automated systems are provided for clinical and anatomical pathology labs. |
Detailed competitors of Synthace
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synthace
The website of Synthace (synthace.com) receives about 19.8K visits a month.
- Monthly visits19.8K
▼ 16% vs previous month
Websites whose visitors overlap most with Synthace. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
shop.sartorius.com | shop.sartorius.com | 100% | – | #552,012 | – |
neb-online.de | neb-online.de | 100% | – | #848,510 | – |
| biopharminternational.com | 100% | 55.1K | #674,468 | View details | |
| sigmaxl.com | 83% | 19.2K | #1,472,606 | View details | |
| nature.com | 81% | 33.6M | #1,922 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Synthace
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Synthace
Complete news archive for Synthace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Synthace
10 companies that operate in the same segment as Synthace (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synthace
Synthace was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Synthace is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Markus Christian Gershater is the current CEO of Synthace. They have also founded this company.
Synthace is a funded company, having raised a total of $80.27M across 8 funding rounds to date. The company's 1st funding round was a Seed of $965K, raised on Apr 2012.
Synthace has 68 employees.
Annual revenue of Synthace is $2.41M as on Jan 31, 2023.
Synthace was founded in 2011 in London, United Kingdom, within the biotechnology sector. SaaS-based software for laboratory automation is offered to researchers, enabling experiment automation through products like Antha. An interoperable system is included for error detection and can be reprogrammed to manage liquid handling in biological experiments. Operations focus on streamlining research workflows across global labs.
Synthace's top competitors include Tecan, Waters Corporation and Automata.
Synthace offers Synthace Software, DOE Training Course, and Dilution Calculator.
Synthace has 9 investors. Key investors include Horizons Ventures, Sofinnova Partners, SOSV, Luminous Ventures, and Amadeus Capital Partners.
The valuation of Synthace is $71.3M as of Dec 2018.
Synthace operates through Synthace Limited.